Mytrus, a provider of clinical technology and services, has sold a significant equity stake to inVentiv Health, a provider of clinical, commercial and consulting services to the healthcare industry. Based in San Francisco, Mytrus allows clinical trial sponsors to use electronic informed consent, allowing a wider range of people to participate in clinical research by removing location as an obstacle to recruitment and bringing trials directly to participants in their homes. The company previously raised $2.1 million of funding in November 2010. InVentiv is a portfolio company of Thomas H. Lee Partners and Liberty Lane Partners.
